Overview
Goals and Objectives
Our Team
Lines of Research
Collaborations
Publications
Projects
We aim to utilize the One Health approach to tackle viral and parasitic infections of major significance.
Using selected viral/parasitic pathogens, we will investigate features that are core to pathogen persistence, diversification, and disease, including biology, metabolism, gene expression, drug resistance, immune evasion, invasiveness, differentiation, at the population and cellular levels, and pathogenesis.
- Identification of viruses/parasites associated with common diseases in the UAE
- Identify host genes interacting with disease-relevant viruses and parasites
- Perform functional studies in viral and parasitic disease models to elucidate molecular mechanisms
- Discovery of novel antimicrobial agents against selected viruses and parasites of human importance
- Prof. Ishtiaq Qadri, King Abdulaziz Univrsity, Saudi Arabi
- Dr. Sutherland Maciver, University of Edinburgh, UK
- Prof. Muhammad Raza Shah, International Center for Chemical and Biological Sciences, H.E.J. Research Institute of Chemistry, Pakistan
- Prof. Kwang Sik Kim, Johns Hopkins University, USA
- Prof. Noorjahan Panjwani, Tufts University, USA.
Research Publications
No Record Found
Internal Projects:
# | Title | PI | Co-PIs | Amount | Dates |
1 | Research funding from the Research & Graduate Studies Central Fund, University of Sharjah for project entitled, “Gut microbiome under microgravity environment". | Naveed Khan | 39000/- | Jul 21 – Jul 23 | |
2 | Molecular interactions of brain-eating amoebae with host cells" | PI | AED=200,000/- | 2022-2024 | |
University of Sharjah, UAE for the Targeted Impactful Research |
External Projects:
# | Title | PI & Co-PIs | Cash Amount Transferred to UoS | Dates | Funding Organization |
1 | Gut microbiome and epigenetic changes under acute stress" | PI | USD 300,000/- | 2023-2026 | US Office of Aerospace and Research and Development, USA. |
2 | Targeting LPS endotoxin of gram-negative bacteria for treatment of sepsis and antimicrobial resistance. | Co-PI | USD 200,000/ - | 2023 - 2025 | NIH, USA/ MBRU, UAE. |
3 | Gut microbiome and human health" | Co-PI | 2022 - 2024 | NASA, USA/ MBRSC, UAE for the Human Exploration Research Analog Mission (HERA). | |
4 | research funding from the Collaborative Stimulus Research Grant, MBRU/UoS for project entitled, “Discovery of novel antimicrobials". | PI | AED=125,000/- | Jul 22 – Jul 23 | CSRG MBRU/UoS |
5 | Metagenomics profiling of the intracellular microbiome of environmental Acanthamoeba isolates and its role in pathogenicity. | Co-PI | AED=128,000/- | Sep 2022 – Sep 2024 | Ministry of Higher Education, Government of Malaysia |
6 | Unravelling the interactions of Acanthamoeba as a universal host with bacterial endosymbionts: One bridge from environment to host pathogenicity. | Co-PI | AED= 50,000/- | Sep 2021 – Sep 2023 | Penyelidikan dan Inovasi, Universiti Technologi MARA, Malaysia |
7 | research funding from the US Office of Aerospace and Research and Development for project entitled, “Novel metabolites(s) from crocodile gut microbiome". | Co-PI | AED= 800,000/- | Aug 20 – Aug 23 | The US Office of Aerospace and Research and Development |
8 | research funding from the FRG, American University of Sharjah for project entitled, “Pests as source of antibacterials". | PI | AED= 520,000/- | Aug 21 – Aug 23 | American University of Sharjah |
9 | research funding from the FRG, American University of Sharjah for project entitled, “Molecular mechanisms of Naegleria fowleri interactions with human cells". | PI | AED= 147,000/- | Aug 21 – Aug 23 | American University of Sharjah |